Loading…
Reported covered position: VP Government Affairs
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2015 · third_quarter · Q3
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
Source: Senate LDA
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 Prescription drug abuse - Medicare Pharmacy and Provider lock-in
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 CY 2016 Notice of Benefit and Payment Parameters (CMS-9944-P)
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 Prescription drug abuse - Medicare Pharmacy and Provider lock-in
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 CY 2016 Notice of Benefit and Payment Parameters (CMS-9944-P)
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
Ensuring Seniors Access to Local Pharmacies Act of 2015
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 CY 2016 Notice of Benefit and Payment Parameters (CMS-9944-P)
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 Prescription drug abuse - Medicare Pharmacy and Provider lock-in
Preserving Our Hometown Independent Pharmacies Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription drug abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 POlicy and Technical CHanges to the Medicare Advantage and Medicare Prescription Drug Program
Preserving Our Hometown Independent Pharmacies Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription Drug Abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug benefit Program
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription drug abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 POlicy and Technical CHanges to the Medicare Advantage and Medicare Prescription Drug Program
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription Drug Abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug benefit Program
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 460 Patients' Access to Treatments Act of 2013 - importance of specialty formulary tiers HR 3392 Medicare Part D Patient Safety and Drug Abuse PRevention Act of 2013 - support safe pharmacies and access to controlled substances Prescription drug abuse and support for funding of state prescription drug monitoring databases HR 4577 Ensuring Seniors Access to Local Pharmacies Act of 2014 - network adequacy; support use of tiered networks
Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 4577 Ensuring Seniors Access to Local Pharmacies Act of 2014 - network adequacy HR 460 Patients Acces to Treatments Act - importance of specialty formulary tiers HR 3392 Medicare Part D Patient Safety and Drug Abuse Prevention - support safe pharmacies and access to controlled substances Prescription drug abuse issues - including support for funding of state prescription drug monitoring databases
Prescription Drug Abuse. Support of the Alliance to Prevent the Abuse of Medicines legislative priorities including minimum requirements for state databases, pharmacy lock-in programs, and abuse deterrent technology. Biosimilars - concerns regarding naming (shared names with reference product vs. original names); specialty drug cost trends HR 4577 Ensuring Seniors Access to Local Pharmacies Act - opposed HR 460 Patients Access to Treatment Act - opposed HR 4437 Medication Therapy Empowerment Act - oppose expanding to one condition
Prescription Drug Abuse. Support of the Alliance to Prevent the Abuse of Medicines legislative priorities including minimum requirements for state databases, pharmacy lock-in programs, and abuse deterrent technology. Biosimilars - concerns regarding naming (shared names with reference product vs. original names); specialty drug cost trends HR 4577 Ensuring Seniors Access to Local Pharmacies Act - opposed HR 460 Patients Access to Treatment Act - opposed HR 4437 Medication Therapy Empowerment Act - oppose expanding to one condition
Ensuring Seniors Access to Local Pharmacies Act of 2014
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 4577 Ensuring Seniors Access to Local Pharmacies Act of 2014 - network adequacy HR 460 Patients Acces to Treatments Act - importance of specialty formulary tiers HR 3392 Medicare Part D Patient Safety and Drug Abuse Prevention - support safe pharmacies and access to controlled substances Prescription drug abuse issues - including support for funding of state prescription drug monitoring databases
Ensuring Seniors Access to Local Pharmacies Act of 2014
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription Drug Abuse. Support of the Alliance to Prevent the Abuse of Medicines legislative priorities including minimum requirements for state databases, pharmacy lock-in programs, and abuse deterrent technology. Biosimilars - concerns regarding naming (shared names with reference product vs. original names); specialty drug cost trends HR 4577 Ensuring Seniors Access to Local Pharmacies Act - opposed HR 460 Patients Access to Treatment Act - opposed HR 4437 Medication Therapy Empowerment Act - oppose expanding to one condition
Ensuring Seniors Access to Local Pharmacies Act of 2014
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription Drug Abuse. Support of the Alliance to Prevent the Abuse of Medicines legislative priorities including minimum requirements for state databases, pharmacy lock-in programs, and abuse deterrent technology. Biosimilars - concerns regarding naming (shared names with reference product vs. original names); specialty drug cost trends HR 4577 Ensuring Seniors Access to Local Pharmacies Act - opposed HR 460 Patients Access to Treatment Act - opposed HR 4437 Medication Therapy Empowerment Act - oppose expanding to one condition
Ensuring Seniors Access to Local Pharmacies Act of 2014
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 460 Patients' Access to Treatments Act of 2013 - importance of specialty formulary tiers HR 3392 Medicare Part D Patient Safety and Drug Abuse PRevention Act of 2013 - support safe pharmacies and access to controlled substances Prescription drug abuse and support for funding of state prescription drug monitoring databases HR 4577 Ensuring Seniors Access to Local Pharmacies Act of 2014 - network adequacy; support use of tiered networks
Patients' Access to Treatments Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription Drug Abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug benefit Program
Patients' Access to Treatments Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 4577 Ensuring Seniors Access to Local Pharmacies Act of 2014 - network adequacy HR 460 Patients Acces to Treatments Act - importance of specialty formulary tiers HR 3392 Medicare Part D Patient Safety and Drug Abuse Prevention - support safe pharmacies and access to controlled substances Prescription drug abuse issues - including support for funding of state prescription drug monitoring databases
Patients' Access to Treatments Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription drug abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 POlicy and Technical CHanges to the Medicare Advantage and Medicare Prescription Drug Program
Patients' Access to Treatments Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription Drug Abuse. Support of the Alliance to Prevent the Abuse of Medicines legislative priorities including minimum requirements for state databases, pharmacy lock-in programs, and abuse deterrent technology. Biosimilars - concerns regarding naming (shared names with reference product vs. original names); specialty drug cost trends HR 4577 Ensuring Seniors Access to Local Pharmacies Act - opposed HR 460 Patients Access to Treatment Act - opposed HR 4437 Medication Therapy Empowerment Act - oppose expanding to one condition
Patients' Access to Treatments Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription Drug Abuse. Support of the Alliance to Prevent the Abuse of Medicines legislative priorities including minimum requirements for state databases, pharmacy lock-in programs, and abuse deterrent technology. Biosimilars - concerns regarding naming (shared names with reference product vs. original names); specialty drug cost trends HR 4577 Ensuring Seniors Access to Local Pharmacies Act - opposed HR 460 Patients Access to Treatment Act - opposed HR 4437 Medication Therapy Empowerment Act - oppose expanding to one condition
Patients' Access to Treatments Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 460 Patients' Access to Treatments Act of 2013 - importance of specialty formulary tiers HR 3392 Medicare Part D Patient Safety and Drug Abuse PRevention Act of 2013 - support safe pharmacies and access to controlled substances Prescription drug abuse and support for funding of state prescription drug monitoring databases HR 4577 Ensuring Seniors Access to Local Pharmacies Act of 2014 - network adequacy; support use of tiered networks
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription drug abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 POlicy and Technical CHanges to the Medicare Advantage and Medicare Prescription Drug Program
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prescription Drug Abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug benefit Program
Preserving Our Hometown Independent Pharmacies Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 867: The Medicare Prescription Drug Program Integrity and Transparency Act of 2013 2014 Final Call Letter Medicare Part D (Preferred pharmacy networks, auto refill through mail service pharmacies) S.117 Medicare Prescription Drug Price Negotiation Act of 2013 H.R. 1188: Preserving Our Hometown Independent Pharmacies Act of 2013
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness ActSpecialty drug costs
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs
Medicare Prescription Drug Price Negotiation Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 867: The Medicare Prescription Drug Program Integrity and Transparency Act of 2013 2014 Final Call Letter Medicare Part D (Preferred pharmacy networks, auto refill through mail service pharmacies) S.117 Medicare Prescription Drug Price Negotiation Act of 2013 H.R. 1188: Preserving Our Hometown Independent Pharmacies Act of 2013
Medicare Prescription Drug Price Negotiation Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 867: The Medicare Prescription Drug Program Integrity and Transparency Act of 2013 2014 Final Call Letter Medicare Part D (Preferred pharmacy networks, auto refill through mail service pharmacies) S.117 Medicare Prescription Drug Price Negotiation Act of 2013
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness ActSpecialty drug costs
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness ActSpecialty drug costs
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 867: The Medicare Prescription Drug Program Integrity and Transparency Act of 2013 2014 Final Call Letter Medicare Part D (Preferred pharmacy networks, auto refill through mail service pharmacies) S.117 Medicare Prescription Drug Price Negotiation Act of 2013
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 867: The Medicare Prescription Drug Program Integrity and Transparency Act of 2013 2014 Final Call Letter Medicare Part D (Preferred pharmacy networks, auto refill through mail service pharmacies) S.117 Medicare Prescription Drug Price Negotiation Act of 2013 H.R. 1188: Preserving Our Hometown Independent Pharmacies Act of 2013
Preserving Our Hometown Independent Pharmacies Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Express Scripts Medco Merger Pharmacy Benefit Manager Audit Reform (S. 1058) Pharmacy anti-trust (H.R. 1946)
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act (pharmacy audits) Proposed rule - Standards Related to Essential Health Benefits
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prime Specialty Pharmacy Facility Opening H.R. 4215 Medicare Pharmacy Transparency and Fair Auditing Act H.R. 1971 Pharmacy Competition and Consumer Choice Act of 2011 S. 1058 Pharmacy Competition and Consumer Choice Act of 2011
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Specialty pharmacy facility opening H.R. 4215: Medicare Pharmacy Transparency and Fair Auditing Act H.R. 1971: Pharmacy Competition and Consumer Choice Act of 2011 S. 1058: Pharmacy Competition and Consumer Choice Act of 2011
To suspend temporarily the duty on nightlights of plastic.
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
S. 1789 21st Century Postal Service Act of 2012 H.R. 2039 Postal Reform Act of 2011
S. 1789: 21st Century Postal Service Act of 2012 H.R. 2309: Postal Reform Act of 2011
Medicare Pharmacy Transparency and Fair Auditing Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prime Specialty Pharmacy Facility Opening H.R. 4215 Medicare Pharmacy Transparency and Fair Auditing Act H.R. 1971 Pharmacy Competition and Consumer Choice Act of 2011 S. 1058 Pharmacy Competition and Consumer Choice Act of 2011
Medicare Pharmacy Transparency and Fair Auditing Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Specialty pharmacy facility opening H.R. 4215: Medicare Pharmacy Transparency and Fair Auditing Act H.R. 1971: Pharmacy Competition and Consumer Choice Act of 2011 S. 1058: Pharmacy Competition and Consumer Choice Act of 2011
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Specialty pharmacy facility opening H.R. 4215: Medicare Pharmacy Transparency and Fair Auditing Act H.R. 1971: Pharmacy Competition and Consumer Choice Act of 2011 S. 1058: Pharmacy Competition and Consumer Choice Act of 2011
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
H.R. 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act (pharmacy audits) Proposed rule - Standards Related to Essential Health Benefits
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Express Scripts Medco Merger Pharmacy Benefit Manager Audit Reform (S. 1058) Pharmacy anti-trust (H.R. 1946)
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Prime Specialty Pharmacy Facility Opening H.R. 4215 Medicare Pharmacy Transparency and Fair Auditing Act H.R. 1971 Pharmacy Competition and Consumer Choice Act of 2011 S. 1058 Pharmacy Competition and Consumer Choice Act of 2011
Preserving Our Hometown Independent Pharmacies Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform
Preserving Our Hometown Independent Pharmacies Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1946 Pharmacy Anti-trust S 1058/HR1971 Pharmacy Competition and Consumer Choice Act Mail service pharmacy
Preserving Our Hometown Independent Pharmacies Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
Express Scripts/Medco Merger HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies, anti-trust exemption for pharmacies
Preserving Our Hometown Independent Pharmacies Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform HR 605/S 312 - Patients Freedom to Choose Act, repealing PPACA restriction on FSA contributions
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1946 Pharmacy Anti-trust S 1058/HR1971 Pharmacy Competition and Consumer Choice Act Mail service pharmacy
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform HR 605/S 312 - Patients Freedom to Choose Act, repealing PPACA restriction on FSA contributions
HR 605/S 312 - Patients Freedom to Choose Act, repealing PPACA restriction on FSA contributions
HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform HR 605/S 312 - Patients Freedom to Choose Act, repealing PPACA restriction on FSA contributions
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform HR 605/S 312 - Patients Freedom to Choose Act, repealing PPACA restriction on FSA contributions
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1946 Pharmacy Anti-trust S 1058/HR1971 Pharmacy Competition and Consumer Choice Act Mail service pharmacy
Pharmacy Competition and Consumer Choice Act of 2011
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
Community Pharmacy Fairness Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
Patient Health and Real Medication Access Cost Savings Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act
Patient Health and Real Medication Access Cost Savings Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act
Patient Health and Real Medication Access Cost Savings Act of 2009
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
PBM Audit Reform and Transparency Act of 2010
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
PBM Audit Reform and Transparency Act of 2010
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
PBM Audit Reform and Transparency Act of 2010
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
PBM Audit Reform and Transparency Act of 2010
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act
PBM Audit Reform and Transparency Act of 2010
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
PBM Audit Reform and Transparency Act of 2010
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
PBM Audit Reform and Transparency Act of 2010
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act
PBM Audit Reform and Transparency Act of 2010
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
PBM Audit Reform and Transparency Act of 2010
Client: PRIME THERAPEUTICS · Firm: PRIME THERAPEUTICS
HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2015 · second_quarter · Q2
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 CY 2016 Notice of Benefit and Payment Parameters (CMS-9944-P)
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program S.480 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 Prescription drug abuse - Medicare Pharmacy and Provider lock-in
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2015 · first_quarter · Q1
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program
H.R. 793: Ensuring Seniors Access to Local Pharmacies Act of 2015. Importance of pharmacy networks in reducing costs. H.R. 244: MAC Transparency Act. Educating on how MAC pricing helps control costs for consumers. Prescription Drug Abuse - Patient Review and Restriction programs for the Medicare program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2014 · fourth_quarter · Q4
Prescription Drug Abuse. Support of the Alliance to Prevent the Abuse of Medicines legislative priorities including minimum requirements for state databases, pharmacy lock-in programs, and abuse deterrent technology. Biosimilars - concerns regarding naming (shared names with reference product vs. original names); specialty drug cost trends HR 4577 Ensuring Seniors Access to Local Pharmacies Act - opposed HR 460 Patients Access to Treatment Act - opposed HR 4437 Medication Therapy Empowerment Act - oppose expanding to one condition
Prescription Drug Abuse. Support of the Alliance to Prevent the Abuse of Medicines legislative priorities including minimum requirements for state databases, pharmacy lock-in programs, and abuse deterrent technology. Biosimilars - concerns regarding naming (shared names with reference product vs. original names); specialty drug cost trends HR 4577 Ensuring Seniors Access to Local Pharmacies Act - opposed HR 460 Patients Access to Treatment Act - opposed HR 4437 Medication Therapy Empowerment Act - oppose expanding to one condition
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2014 · third_quarter · Q3
HR 4577 Ensuring Seniors Access to Local Pharmacies Act of 2014 - network adequacy HR 460 Patients Acces to Treatments Act - importance of specialty formulary tiers HR 3392 Medicare Part D Patient Safety and Drug Abuse Prevention - support safe pharmacies and access to controlled substances Prescription drug abuse issues - including support for funding of state prescription drug monitoring databases
HR 460 Patients' Access to Treatments Act of 2013 - importance of specialty formulary tiers HR 3392 Medicare Part D Patient Safety and Drug Abuse PRevention Act of 2013 - support safe pharmacies and access to controlled substances Prescription drug abuse and support for funding of state prescription drug monitoring databases HR 4577 Ensuring Seniors Access to Local Pharmacies Act of 2014 - network adequacy; support use of tiered networks
Filing targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2014 · second_quarter · Q2
Prescription drug abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 POlicy and Technical CHanges to the Medicare Advantage and Medicare Prescription Drug Program
Prescription Drug Abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug benefit Program
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2014 · first_quarter · Q1
Proposed rule Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Program - retail pharmacy networks, preferred cost sharing, mail order fulfillment, non interference
Prescription drug abuse
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2013 · fourth_quarter · Q4
Prescription drug abuse - Alliance to Prevent the Abuse of Medicines legislative concenpts
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2013 · third_quarter · Q3
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness ActSpecialty drug costs
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs
HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2013 · second_quarter · Q2
S. 867: The Medicare Prescription Drug Program Integrity and Transparency Act of 2013 2014 Final Call Letter Medicare Part D (Preferred pharmacy networks, auto refill through mail service pharmacies) S.117 Medicare Prescription Drug Price Negotiation Act of 2013
S. 867: The Medicare Prescription Drug Program Integrity and Transparency Act of 2013 2014 Final Call Letter Medicare Part D (Preferred pharmacy networks, auto refill through mail service pharmacies) S.117 Medicare Prescription Drug Price Negotiation Act of 2013 H.R. 1188: Preserving Our Hometown Independent Pharmacies Act of 2013
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2013 · first_quarter · Q1
Notice of benefit and payment parameters for 2014 proposed rule - Cost sharing subsidy reconcilliation methodology Essential health benefits proposed rule - pharmacy benefits Establishment of the multi-state plan program - pharmacy benefit manager transparency requirements Pharmacy compounding
Notice of benefit and payment parameters for 2014 proposed rule - Cost sharing subsidy reconcilliation methodology Essential health benefits proposed rule - pharmacy benefits Establishment of the multi-state plan program - pharmacy benefit manager transparency requirements Pharmacy compounding
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM)
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2012 · fourth_quarter · Q4
H.R. 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act (pharmacy audits) Proposed rule - Standards Related to Essential Health Benefits
Administration of the cost sharing reduction subsidy - proposed rule Benefit and Payment Parameters Essential health benefits - proposed rule for Standards Related to Essential Health Benefits
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2012 · second_quarter · Q2
S. 1789 21st Century Postal Service Act of 2012 H.R. 2039 Postal Reform Act of 2011
Prime Specialty Pharmacy Facility Opening H.R. 4215 Medicare Pharmacy Transparency and Fair Auditing Act H.R. 1971 Pharmacy Competition and Consumer Choice Act of 2011 S. 1058 Pharmacy Competition and Consumer Choice Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2012 · third_quarter · Q3
S. 1789: 21st Century Postal Service Act of 2012 H.R. 2309: Postal Reform Act of 2011
Specialty pharmacy facility opening H.R. 4215: Medicare Pharmacy Transparency and Fair Auditing Act H.R. 1971: Pharmacy Competition and Consumer Choice Act of 2011 S. 1058: Pharmacy Competition and Consumer Choice Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2012 · first_quarter · Q1
Express Scripts Medco Merger Pharmacy Benefit Manager Audit Reform (S. 1058) Pharmacy anti-trust (H.R. 1946)
Health care cost control Essential Health Benefits
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2011 · fourth_quarter · Q4
Essential Health Benefits
Express Scripts/Medco Merger HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies, anti-trust exemption for pharmacies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2011 · third_quarter · Q3
HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform HR 605/S 312 - Patients Freedom to Choose Act, repealing PPACA restriction on FSA contributions
HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform
HR 605/S 312 - Patients Freedom to Choose Act, repealing PPACA restriction on FSA contributions
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2011 · second_quarter · Q2
HR 1946 Pharmacy Anti-trust S 1058/HR1971 Pharmacy Competition and Consumer Choice Act Mail service pharmacy
Medical Loss Ratio Interim Final Rule - treatment of PBM transactions with retail pharmacies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2011 · first_quarter · Q1
Health Insurers Implementing Medical Loss Ratios (MLR) Under the Patient Protection and Affordable Care Act; Interim Final Rule
Health Care Reform
Health Insurers Implementing Medical Loss Ratio (MLR) Requirements Under the Patient Protection and Affordable Care Act; Interim Final Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2010 · fourth_quarter · Q4
HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act
HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act
HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2010 · third_quarter · Q3
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
PRIME THERAPEUTICS via PRIME THERAPEUTICS
2010 · second_quarter · Q2
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 5234 PBM Audit Reform and Transaprency Act, PBM Ownership Interests, Pharmacy Choice, and PBM Audit of Pharmacies HR 4489 FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, Reimbursement of Carriers, Pricing HE 4199 PHARMACY Bill, Reegulation of Pharmacy Benefit Managers HR 1204 Community Pharmacy Fairness Act of 2009, Application of Antitrust Laws to Independent Pharmacies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE